Skip to content

Clinical trials

Obesity, Morbid trials in Spain with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity, Morbid Phase: Not applicable Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20114
20131
20141
20151
20161
20171
20181
20191
20212
20223
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status6
Enrolling by invitation3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Universitari de Bellvitge5
Hospitales Universitarios Virgen del Rocío2
Puerta de Hierro University Hospital2
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental1
Fundación para la Investigación del Hospital Clínico de Valencia1
GI Windows, Inc.1
Hospital Severo Ochoa1
Hospital Universitari Vall d'Hebron Research Institute1
Institut d'Investigació Biomèdica de Bellvitge1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity, Morbid22
Obesity5
Weight Loss4
Postoperative Complications3
Diabetes Mellitus, Type 21
Gastroesophageal Reflux1
Hypoxia1
Metabolic Syndrome1
Overweight1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.